Loading...
Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc. (APLS)

27.17
0.04 (+0.13%)

About


Cedric Francois
Healthcare
Biotechnology
Nasdaq Global Select

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.